Dr Iglesia on the Potential Role for Disease Etiology in Frontline HCC Treatment Selection

Michael Iglesia, MD, PhD, discusses the potential role of disease etiology in frontline HCC treatment decision-making.

Related Keywords

Michael Iglesia ,Division Of Oncology ,Washington University School Of Medicine ,Johnt Milliken Department Of Medicine ,Washington University School ,